Northwestern Mutual Wealth Management CO Verve Therapeutics, Inc. Transaction History

Northwestern Mutual Wealth Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$11.42 - $20.82 $79 - $145	7 New	7 $0
Q4 2022 Feb 21, 2023	BUY	$17.85 - $40.7 $71 - $162	4 New	4 $0
Q2 2022 Aug 04, 2022	BUY	$11.14 - $23.17 $256 - $532	23 New	23 $0
Q1 2022 May 09, 2022	SELL	$20.92 - $39.36 $83 - $157	-4 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$31.94 - $54.82 $127 - $219	4 New	4 $0

182

73.3M

85K

215K

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $456M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.